Free Trial Information
BioCentury | Dec 19, 2005
Strategy

Cyclacel funding history

...Ventures; and Scottish Equity Partners 1/29/04 Series D $39.0 SG Asset Management; Carnegie Asset Management; DC Thomson...
Read More
BioCentury | May 17, 2004
Finance

U.S. investment in Europe

...Ventures; Wellcome Trust; and other investors Cyclacel U.K. $39.0 SG Asset Management; Carnegie Asset Management; DC Thomson...
Read More
Items per page:
1 - 2 of 2
BioCentury | Dec 19, 2005
Strategy

Cyclacel funding history

...Ventures; and Scottish Equity Partners 1/29/04 Series D $39.0 SG Asset Management; Carnegie Asset Management; DC Thomson...
Read More
BioCentury | May 17, 2004
Finance

U.S. investment in Europe

...Ventures; Wellcome Trust; and other investors Cyclacel U.K. $39.0 SG Asset Management; Carnegie Asset Management; DC Thomson...
Read More
Items per page:
1 - 2 of 2